Susceptibility to colistin: Evaluation of breakpoints available in disk diffusion test;Sensibilidad a colistín: Evaluación de los puntos de corte disponibles en el antibiograma por difusión

Revista Argentina de Microbiologia

Volumn 36, Issue 3, 2004, Pages 125-129

  Rodriguez C H ^a   Pautaso, J ^b   Bombicino, K ^b   Vay, C ^a   Famiglietti, A ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Colistin susceptibility; Gram negative rods; Susceptibility test

Indexed keywords

CARBAPENEM; COLISTIN; POLYMYXIN DERIVATIVE;

AGAR GEL DIFFUSION; ANALYTICAL ERROR; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARGENTINA; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; DILUTION; EVALUATION; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN;

ADULT; CHILD; COLISTIN; DIFFUSION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENDPOINT DETERMINATION; FALSE POSITIVE REACTIONS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMYXINS; PROSPECTIVE STUDIES;

EID: 8344254357     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Antimicrobial susceptibility testing: BSAC working party report (2001) J. Antimicrob. Chemother. 48: 1-161.
2. D'amato RF, Thornsberry C, Baker CN, Kirven L (1975) Effect of calcium and magnesium ions on the susceptibility of Pseudomonas species to tetracycline, gentamicin, polimyxyna B and carbenicillin. Antimicrob. Agents Chemoter. 7: 596-600.
3. Gales A, Reis A, Jones R (2001) Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J. Clin. Microbiol. 39: 183-190.
4. Gales A, Jones R, Forward KR, Liñares J, Sader HS, Verhoef J (2001) Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997-1999). Clin. Infect. Dis. 32 (Suppl 2): S104-113.
5. Levin AS, Barone A, Penco J, Santos M, Marinho I, Arruda E, Manrique E, Costa S (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin. Infect. Dis. 28: 1008-1011.
6. National Committee for Clinical Laboratory Standards. (1981) Performance standards for antimicrobic disc susceptibility test. Approved standard M2-A2 S2. National Committee for Clinical Laboratory Standards. Wayne Pa. EEUU.
7. National Committee for Clinical Laboratory Standards. (2002) Performance standard for antimicrobial susceptibility testing. Document M100-S10. National Committee for Clinical Laboratory Standards, Wayne, Pa. EEUU.
8. Nicas TI, Hancock REW (1980) Outer membrane protein H1 of Pseudomonas aeruginosa: involvement in adaptative and mutational resistance to ethylenediaminetetraacetate, polymyxin B and gentamicin. J. Bacteriol. 143: 872-878.
9. Reis A O, Luz Dam, Tognim M, Sader H, and Gales A (2003) Polymyxin resistant Acinetobacter spp. isolates: what is next? Emerg. Infect. Dis. 9: 50-51
10. Soussy CJ, Carret G, Cavallo JD, Chardon H, Chidiac C, et al. (2000) Antibiogram Committee of the French Microbiology Society. Report 2000-2001. Pathol. Biol. (Paris) 48: 832-871.
11. st century? Clin. Infect. Dis. 35: 901.